TG THERAPEUTICS, INC. - Common Stock (TGTX)

CUSIP: 88322Q108

Q2 2021 13F Holders as of 30 Jun 2021

Type / Class
Equity / Common Stock
Shares outstanding
158,835,667
Total 13F shares
96,046,069
Share change
-2,875,521
Total reported value
$3,725,506,174
Put/Call ratio
92%
Price per share
$38.79
Number of holders
232
Value change
-$125,135,262
Number of buys
122
Number of sells
113

Sponsored

Quarterly Holders Quick Answers

What is CUSIP 88322Q108?
CUSIP 88322Q108 identifies TGTX - TG THERAPEUTICS, INC. - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Top shareholders of TGTX - TG THERAPEUTICS, INC. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
FMR LLC
13F
Company
11%
17,970,651
$866,185,000 31 Mar 2021
13F
VANGUARD GROUP INC
13F
Company
7%
11,124,376
$536,194,000 31 Mar 2021
13F
BlackRock Finance, Inc.
13F
Company
5.9%
9,299,599
$448,240,000 31 Mar 2021
13F
LORD, ABBETT & CO. LLC
13F
Company
3%
4,695,301
$226,314,000 31 Mar 2021
13F
RA CAPITAL MANAGEMENT, L.P.
13F
Company
2.9%
4,636,146
$223,462,000 31 Mar 2021
13F
WELLINGTON MANAGEMENT GROUP LLP
13F
Company
2.7%
4,316,761
$208,068,000 31 Mar 2021
13F
ALKEON CAPITAL MANAGEMENT LLC
13F
Company
2.6%
4,090,691
$197,171,000 31 Mar 2021
13F
STATE STREET CORP
13F
Company
2.1%
3,259,281
$157,097,000 31 Mar 2021
13F
Capital World Investors
13F
Company
2%
3,153,943
$152,020,000 31 Mar 2021
13F
MAVERICK CAPITAL LTD
13F
Company
1.9%
2,971,136
$143,209,000 31 Mar 2021
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
1.3%
2,047,432
$98,686,000 31 Mar 2021
13F
PRICE T ROWE ASSOCIATES INC /MD/
13F
Company
1%
1,617,341
$77,956,000 31 Mar 2021
13F
Artal Group S.A.
13F
Company
0.94%
1,500,000
$72,300,000 31 Mar 2021
13F
NORTHERN TRUST CORP
13F
Company
0.84%
1,334,593
$64,327,000 31 Mar 2021
13F
GOLDMAN SACHS GROUP INC
13F
Company
0.84%
1,329,380
$64,076,000 31 Mar 2021
13F
Invesco Ltd.
13F
Company
0.69%
1,100,895
$53,064,000 31 Mar 2021
13F
NORGES BANK
13F
Company
0.67%
1,071,846
$51,663,000 31 Mar 2021
13F
S.c.a. Candriam
13F
Individual
0.64%
1,010,227
$50,480,000 31 Mar 2021
13F
PICTET ASSET MANAGEMENT LTD
13F
Company
0.66%
1,041,271
$50,189,000 31 Mar 2021
13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP
13F
Company
0.6%
946,634
$45,628,000 31 Mar 2021
13F
Woodline Partners LP
13F
Company
0.58%
926,766
$44,670,000 31 Mar 2021
13F
EAGLE ASSET MANAGEMENT INC
13F
Company
0.52%
831,547
$40,712,000 31 Mar 2021
13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC
13F
Company
0.53%
840,963
$40,535,000 31 Mar 2021
13F
BANK OF AMERICA CORP /DE/
13F
Company
0.49%
778,016
$37,500,000 31 Mar 2021
13F
Eversept Partners, LP
13F
Company
0.48%
762,589
$36,756,790 31 Mar 2021
13F
Nuveen Asset Management, LLC
13F
Company
0.43%
676,609
$32,613,000 31 Mar 2021
13F
Nicholas Investment Partners, LP
13F
Company
0.39%
625,787
$30,163,000 31 Mar 2021
13F
Lion Point Capital, LP
13F
Company
0.38%
609,128
$29,359,000 31 Mar 2021
13F
D. E. Shaw & Co., Inc.
13F
Company
0.34%
535,001
$25,787,000 31 Mar 2021
13F
SECTORAL ASSET MANAGEMENT INC
13F
Company
0.32%
513,649
$24,758,000 31 Mar 2021
13F
Bank of New York Mellon Corp
13F
Company
0.32%
510,079
$24,585,000 31 Mar 2021
13F
FARALLON CAPITAL MANAGEMENT LLC
13F
Company
0.31%
500,000
$24,100,000 31 Mar 2021
13F
GROUP ONE TRADING LLC
13F
Company
0.31%
491,256
$23,679,000 31 Mar 2021
13F
VICTORY CAPITAL MANAGEMENT INC
13F
Company
0.28%
446,587
$21,525,000 31 Mar 2021
13F
PANAGORA ASSET MANAGEMENT INC
13F
Company
0.24%
386,195
$18,615,000 31 Mar 2021
13F
CREDIT SUISSE AG/
13F
Company
0.24%
382,359
$18,430,000 31 Mar 2021
13F
Hood River Capital Management LLC
13F
Company
0.23%
372,738
$17,966,000 31 Mar 2021
13F
MILLENNIUM MANAGEMENT LLC
13F
Company
0.2%
316,471
$15,254,000 31 Mar 2021
13F
ARDSLEY ADVISORY PARTNERS LP
13F
Company
0.19%
300,000
$14,460,000 31 Mar 2021
13F
CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM
13F
Company
0.19%
293,968
$14,169,000 31 Mar 2021
13F
EMERALD MUTUAL FUND ADVISERS TRUST
13F
Company
0.17%
277,154
$13,359,000 31 Mar 2021
13F
Rock Springs Capital Management LP
13F
Company
0.17%
266,520
$12,846,000 31 Mar 2021
13F
BRIDGER MANAGEMENT, LLC
13F
Company
0.16%
256,897
$12,382,000 31 Mar 2021
13F
Pier Capital, LLC
13F
Company
0.16%
253,271
$12,208,000 31 Mar 2021
13F
EMERALD ADVISERS, LLC
13F
Company
0.16%
251,857
$12,140,000 31 Mar 2021
13F
683 Capital Management, LLC
13F
Company
0.15%
243,271
$11,726,000 31 Mar 2021
13F
Swiss National Bank
13F
Company
0.15%
240,300
$11,582,000 31 Mar 2021
13F
ALLIANCEBERNSTEIN L.P.
13F
Company
0.14%
218,350
$10,524,000 31 Mar 2021
13F
CASTLEARK MANAGEMENT LLC
13F
Company
0.14%
217,631
$10,490,000 31 Mar 2021
13F
RAYMOND JAMES & ASSOCIATES
13F
Company
0.13%
204,992
$9,881,000 31 Mar 2021
13F

Institutional Holders of TG THERAPEUTICS, INC. - Common Stock (TGTX) as of Q2 2021

As of 30 Jun 2021, TG THERAPEUTICS, INC. - Common Stock (TGTX) was held by 232 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 96,046,069 shares. The largest 10 holders included FMR LLC, VANGUARD GROUP INC, BlackRock Inc., WELLINGTON MANAGEMENT GROUP LLP, Capital World Investors, ALKEON CAPITAL MANAGEMENT LLC, STATE STREET CORP, RA CAPITAL MANAGEMENT, L.P., LORD, ABBETT & CO. LLC, and MAVERICK CAPITAL LTD. This page lists 233 institutional shareholders reporting positions in this security for the Q2 2021 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q2 2021 vs Q1 2021 Across Filers

Q1 2021 holders
233
Q2 2021 holders
232
Holder diff
-1
Investor Q1 2021 Shares Q2 2021 Shares Share Diff Share Chg % Q1 2021 Value $ Q2 2021 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.